Registry of SARS-CoV-2 infection in patients with hemoglobinopathies and / or splenectomies: epidemiological surveillance and study of morbidity and mortality in risk groups
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:0 publications
Grant number: COV20_00675
Grant search
Key facts
Disease
COVID-19Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
Elena Cela de JuliánResearch Location
SpainLead Research Institution
FUNDACION INVESTIGACION BIOMEDICA HOSPITAL GREGORIO MARAÑONResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease susceptibility
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The SARS-CoV-2 infection registry in pediatric patients with clinically serious hemoglobinopathies, such as sickle cell disease (SCD) or Thalassemia major (TM), among others, and / or splenectomized patients aims to collect relevant epidemiological information for the surveillance of this risk group; It is intended to study the morbidity and mortality in this population in addition to the quantification of the resources used by this population during the current epidemic situation (hospitalization rate, treatments used, admission rate to intensive care units, among other markers). of an observational, descriptive, multicenter and ambispective study. With this study we want to study the socioeconomic impact and epidemiology of the COVID-19 disease in this population group.